AKT1 and hepatocellular carcinoma: On the other hand, HCC cells were incubated in complete medium supplemented with 3-methyladenine (3-MA, an autophagy inhibitor), then added PI3K inhibitor (LY294002) and AKT inhibitor (MK2206).